|
|
|
ABSI Description — Absci Corp
Absci is a generative artificial intelligence (AI) drug creation company utilizing deep learning and synthetic biology for therapeutic potential of proteins. Co. utilizes its integrated drug creation platform to identify drug targets and create biotherapeutic candidates. Co.'s Integrated Drug Creation platform combines: the data to train, in which its SoluPro technology constructs genetically-distinct cells; the AI to Create, which designs new therapeutic candidates using generative AI models; and the wet lab to validate, which supports its generative AI designs with its wet lab's throughput functional validation capabilities.
Company Name: |
Absci Corp |
Website: |
www.absci.com |
Sector: |
Biotechnology |
Number of ETFs Holding ABSI: |
6 |
Total Market Value Held by ETFs: |
$36,887,351 |
Total Market Capitalization: |
$585,000,000 |
% of Market Cap. Held by ETFs: |
6.31% |
|
ETF |
ABSI Weight |
ABSI Amount |
ARKG |
1.29% |
$17,781,956 |
VTI |
0.00% |
$12,894,543 |
VXF |
0.00% |
$4,886,802 |
IWC |
0.08% |
$683,018 |
ITOT |
0.00% |
$641,032 |
WDNA |
0.00% |
$$0 |
|
|
|
|
Strong Buy (3.67 out of 4)
67th percentile
|
|
|